# A Study for Type 2 Diabetic Patients

> **NCT00548808** · PHASE4 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 426 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Insulin lispro low mixture
- **DRUG:** Insulin glargine
- **DRUG:** Insulin lispro

## Key facts

- **NCT ID:** NCT00548808
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 426 (ACTUAL)
- **Last updated:** 2010-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00548808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00548808, "A Study for Type 2 Diabetic Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00548808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*